Onegaba Side Effects

300 & 400 mg: The adverse reactions in epilepsy (adjunctive and monotherapy) and neuropathic pain have been provided in a single list as follows by class and frequency (very common >1/10), common (>1/100, <1/10), uncommon (>1/1000, <1/100) and rare (>1/10000, <1/1,000).
Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Infections and infestations: Very common: Viral infection. Common: Pneumonia, respiratory infection, urinary tract infection, infection, otitis media.
Blood and the lymphatic system disorders: Common: leucopenia. Rare: thrombocytopenia.
Immune system disorders: Rare: allergic reactions (e.g. urticaria).
Metabolism and Nutrition Disorders: Common: anorexia, increased appetite.
Psychiatric disorders: Common: hostility, confusion and emotional lability, depression, anxiety, nervousness, thinking abnormal. Rare: hallucinations.
Nervous system disorders: Very Common: somnolence, dizziness, ataxia. Common: convulsions, hyperkinesias, dysarthria, amnesia, tremor, insomnia, headache, sensations such as paresthesia, hypaesthesia, coordination abnormal, nystagmus, increased, decreased or absent reflexes. Rare: movement disorders (e.g. choreoathetosis, dyskinesia, dystonia).
Eye disorders: Common: visual disturbances such as ambiyopia, diplopia.
Ear and labyrinth disorders: Common: vertigo. Rare: tinnitus.
Cardiac disorders: Rare: palpitations.
Vascular disorder: Common: hypertension, vasodilatation.
Respiratory, thoracic and mediastinal disorders: Common: dyspnea, bronchitis, pharyngitis, cough, rhinitis.
Gastrointestinal disorders: Common: vomiting, nausea, dental abnormalities, gingivitis, diarrhea, abdominal pain, dyspepsia, constipation, dry mouth or throat, flatulence. Rare: pancreatitis.
Hepatobiliary disorders: Rare: hepatitis, jaundice.
Skin and subcutaneous tissue disorders: Common: facial oedema, purpura most often described as bruises resulting from physical trauma, rash, pruritus, and acne. Rare: Stevens-Johnson syndrome, angioedema, erythema multiforme, alopecia.
Musculoskeletal, connective tissue and bone disorders: Common: arthralgia, myalgia, back pain, twitching.
Renal and urinary disorders: Common: Incontinence. Rare: acute renal failure.
Reproductive system and breast disorders: Common: impotence.
600 mg: The adverse reactions observed during clinical studies conducted in epilepsy adjunctive Therapy frequently occurring treatment-emergent signs and symptoms during placebo controlled studies are summarized as follows: Body as a Whole: Asthenia, malaise, facial edema.
Cardiovascular System: Hypertension.
Digestive System: Flatulence, anorexia, gingivitis.
Hemic/Lymphatic Systems: Purpura most often described as bruises resulting from physical trauma.
Musculoskeletal System: Arthralgia.
Nervous System: Vertigo; hyperkinesia; increased, decreased or absent reflexes; paresthesia, anxiety, hostility.
Respiratory System: Pneumonia.
Urogenital System: Urinary tract infection.
Special Senses: Abnormal vision most often described as a visual disturbance.
Children: The most commonly observed adverse events reported with the use of gabapentin in combination with other antiepileptic drugs in children 3-12 years, not seen in equal frequency among placebo-treated patients, were viral infection, fever, nausea and/or vomiting, and somnolence.